The Upcoming
  • Culture
    • Art
    • Cinema & Tv
      • Movie reviews
      • Film festivals
      • Shows
    • Food & Drinks
      • News & Features
      • Restaurant & bar reviews
      • Interviews & Recipes
    • Literature
    • Music
      • Live music
    • Theatre
  • Fashion & Lifestyle
    • Accessories
    • Beauty
    • News & Features
    • Shopping & Trends
    • Tips & How-tos
    • Fashion weeks
  • What’s On
    • Art exhibitions
    • Theatre shows
  • Tickets
  • Join us
    • Editorial unit
    • Our writers
    • Join the team
    • Join the mailing list
    • Support us
    • Contact us
  • Interviews
  • Competitions
  • Special events
    • Film festivals
      • Berlin
      • Tribeca
      • Sundance London
      • Cannes
      • Locarno
      • Venice
      • London
      • Toronto
    • Fashion weeks
      • London Fashion Week
      • New York Fashion Week
      • Milan Fashion Week
      • Paris Fashion Week
      • Haute Couture
      • London Fashion Week Men’s
  • Facebook

  • Twitter

  • Instagram

  • YouTube

  • RSS

Archive

U-turn on prostate cancer pill

U-turn on prostate cancer pill
16 May 2012
Abbie Cavendish
Avatar
Abbie Cavendish
16 May 2012

The NHS’ rationing body, the National Institute for Health and Clinical Excellence (NICE) is poised to retract its ban on a drug to treat advanced prostate cancer in men receiving chemotherapy. 

The head of Cancer Research, Harpal Kumar, praised NICE for overturning a decision denying prostate cancer sufferers access to a life-extending drug.

The head of Cancer Research, Harpal Kumar, praised NICE for overturning a decision denying prostate cancer sufferers access to a life-extending drug.

Abiraterone was originally judged too expensive by NICE, with a month’s treatment costing around £3000. Following the decision in February, however, NICE faced heavy criticism from Cancer Research UK and was urged by the Department of Health to overturn the decision.

Research has shown that the drug, taken as a tablet, can prolong the life of cancer sufferers by four months more than any other treatment, while at the same time relieving pain in twice as many men as those taking steroids. 

Some patients on the drug have lived far longer than expected, with some in the UK living for around four years in the advanced stages of the cancer. The drug is widely credited with keeping Lockerbie bomber Adelbaset al-Megrahi alive. 

The drug was approved last year in Europe and the United States and will now be legal in England and Wales, though the decision stands in Scotland and will be reviewed. 

Harpal Kumar, the head of Cancer Research UK, said of the decision: “This is wonderful news for patients with advanced prostate cancer.” 

The drug works by blocking the production of testosterone and targeting the tumours themselves. It was discovered by scientists at the Institute of Cancer Research and the Royal Marsden, both situated in London. 

The drug is set to benefit around 3,300 men a year who suffer with the disease, which can become resistant to other hormone-based treatments in its advanced stages. 

Owen Sharp of the Prostate Cancer Charity praised the decision, saying: “This breakthrough drug will make a real difference to men with prostate cancer at the end of life who have no alternative – this is the only hope they have.”

Abbie Cavendish

Related Items

More in Archive

Achieve timeless elegance this S/S 2014 with S.I.L.K.

Ellie Owen
Read More

Bespoke jewellery by Charlotte Tamar

Niten Thakor
Read More

Enjoy designer luxury with Alexis Smith Lingerie’s A/W 2013 collection

Ellie Owen
Read More

Embrace vibrancy and colour with PPQ this winter

Ellie Owen
Read More

Kenzo Metallics adds the sparkle to you Christmas wardrobe

Niten Thakor
Read More

A Christmas alternative: Cranberry and Orange Jeweled Nut Bake

Bethany Stone
Read More

An Austique shopping guide: your one-stop shop for last minute gifts

Christianna Pugliese
Read More

A comforting twist to designer heels

Michelle McGill
Read More

Iain Duncan Smith condemned for refusing to meet with Trussell Trust

Abbie Cavendish
Read More
Scroll for more
Tap
  • Popular

  • Latest

  • TOP PICKS

  • Smith & Burrows – Only Smith & Burrows Is Good Enough
    ★★★★★
    Album review
  • Creation Stories
    ★★★★★
    Film festivals
  • Gatsby at Cadogan Hall: An interview with Jodie Steele and Ross William Wild
    Theatre
  • Detroit Stories – Alice Cooper
    ★★★★★
    Album review
  • Wrong Turn
    ★★★★★
    Movie review
  • My Wonderful Wanda
    ★★★★★
    Film festivals
  • Foster Boy
    Movie review
  • Your Honor
    ★★★★★
    other
  • Maximo Park – Nature Always Wins
    ★★★★★
    Live music
  • The Toll
    ★★★★★
    Film festivals
  • My Favourite War
    ★★★★★
    Film festivals
  • Typical at Soho Theatre
    ★★★★★
    Theatre
  • Detroit Stories – Alice Cooper
    ★★★★★
    Album review
  • Minari
    ★★★★★
    Film festivals
  • West End Musical Drive In Online
    ★★★★★
    Theatre
The Upcoming
Pages
  • Contact us
  • Join mailing list
  • Join us
  • Our London food map
  • Our writers
  • Support us
  • What, when, why

Copyright © 2011-2020 FL Media

When lingerie meets an under duvet with a touch of Champagne
Bionic eye invented at Stanford University